GlassScriptPhysician profile
L Lamar Youmans
NPI 1497726855
$4,261.20
in general payments reported to CMS, 2019-2025
16 companies · $872 in 2025
The $872 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $250 · 2021: $392 · 2022: $601 · 2023: $682 · 2024: $657 · 2025: $872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,095 · Entertainment: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,094.61 |
| Entertainment | $116.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $531.57 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $486.99 | 2019-2025 | Acuvue |
| Biotissue Holdings INC. | $481.78 | 2019-2025 | |
| Alcon Vision LLC | $411.24 | 2019-2025 | Tryptyr, Dailies Total1 |
| Bausch & Lomb Americas INC. | $367.96 | 2022-2025 | Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $359.62 | 2019-2021 | |
| Dompe US, INC. | $312.42 | 2021-2024 | Oxervate |
| Optos, INC. | $283.11 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Glaukos Corporation | $264.91 | 2019-2025 | Idosetr |
| Optovue, INC. | $178.39 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $121.66 | 2023 | Cequa |
| Maculogix, INC. | $105.02 | 2020 | |
| Sight Sciences, INC. | $100.37 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $99.93 | 2025 | Xdemvy |
| Amgen INC. | $84.48 | 2024 | Tepezza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $71.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw L Youmans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.